EMA
- Application: EMEA/H/C/001122
- Local brand name: Impulsor
- Status: refused
MILNACIPRAN (MILNACIPRAN) regulatory status in European Union.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA has authorised it.
Marketing authorisation holder not available in our data.